The role of the allograft in the induction of donor-specific T cell hyporesponsiveness

被引:42
作者
Baker, RJ [1 ]
Hernandez-Fuentes, MP [1 ]
Brookes, PA [1 ]
Chaudhry, AN [1 ]
Lechler, RI [1 ]
机构
[1] Imperial Coll Sch Med, Hammersmith Hosp, Dept Immunol,Dept Renal Med, Div Med, London W12 0NN, England
关键词
D O I
10.1097/00007890-200108150-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. With adequate immunosuppression the majority of renal allografts are accepted, despite the exceptional vigour of the T cell alloimmune response. Previous work from this laboratory has demonstrated that this is accompanied by significant reductions in the precursor frequencies of anti-donor T cells. We have also shown that parenchymal cells are tolerogenic in vitro. We propose that the reduction in T cell frequencies may be due to the interaction between circulating T cells and potentially tolerogenic graft parenchymal cells. Primed/memory T cells (CD45RO(+)) are the only subset capable of reaching the allograft and therefore we would predict that T cell hyporesponsiveness would develop predominantly in the CD45RO(+) subset due to their trafficking properties. Methods. Frequencies of IL-2 secreting CD45RA(+) and CD45RO(+) CD4(+) T cells in response to donor and third party stimulator cells were estimated in a series of renal transplant recipients, both before and after transplantation. Results. There were highly significant reductions in the frequencies of donor-specific CD4(+)CD45RO(+) T cells, when adjusted to control for the generalised effects of immunosuppression. There were no significant alterations in the frequencies of donor-specific CD4(+)CD45RA(+) T cells. Conclusions. In renal transplant recipients, donor-specific CD4(+) T cell hyporesponsiveness occurs predominantly in CD4(+) CD45RO(+) T cells which is the subset capable of trafficking through the graft.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 37 条
  • [1] Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection
    Azuma, H
    Chandraker, A
    Nadeau, K
    Hancock, WW
    Carpenter, CB
    Tilney, NL
    Sayegh, MH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) : 12439 - 12444
  • [2] Benichou G, 1999, J IMMUNOL, V162, P352
  • [3] BERG FMM, 1996, J EXP MED, V183, P1603
  • [4] REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION
    BEVERLY, B
    KANG, SM
    LENARDO, MJ
    SCHWARTZ, RH
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) : 661 - 671
  • [5] Lymphocyte migration into tissue: The paradigm derived from CD4 subsets
    Bradley, LM
    Watson, SR
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (03) : 312 - 320
  • [6] DONOR-RECIPIENT MICROCHIMERISM IS NOT REQUIRED FOR TOLERANCE INDUCTION FOLLOWING RECIPIENT PRETREATMENT WITH DONOR-SPECIFIC TRANSFUSION AND ANTI-CD4 ANTIBODY - EVIDENCE OF A CLEAR ROLE FOR SHORT-TERM ANTIGEN PERSISTENCE
    BUSHELL, A
    PEARSON, TC
    MORRIS, PJ
    WOOD, KJ
    [J]. TRANSPLANTATION, 1995, 59 (10) : 1367 - 1371
  • [7] Lymphocyte homing and homeostasis
    Butcher, EC
    Picker, LJ
    [J]. SCIENCE, 1996, 272 (5258) : 60 - 66
  • [8] Clinical outcome of renal transplantation - Factors influencing patient and graft survival
    Cecka, M
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1998, 78 (01) : 133 - +
  • [9] Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection
    Chandraker, A
    Azuma, H
    Nadeau, K
    Carpenter, CB
    Tilney, NL
    Hancock, WW
    Sayegh, MH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) : 2309 - 2318
  • [10] Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
    Ciubotariu, R
    Liu, ZR
    Colovai, AI
    Ho, E
    Itescu, S
    Ravalli, S
    Hardy, MA
    Cortesini, R
    Rose, EA
    Suciu-Foca, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 398 - 405